Standards of medical care in diabetes 2010
Open accessThe DOI matches its Crossref record; 437 of the 437 references it cites were found in a registry or an index.
Abstract
D iabetes is a chronic illness that requires continuing medical care and ongoing patient self-management education and support to prevent acute complications and to reduce the risk of long-term complications. Diabetes care is complex and requires that many issues, beyond glycemic control, be addressed. A large body of evidence exists that supports a range of interventions to improve diabetes outcomes. These standards of care are intended to provide clinicians, patients, researchers, payors, and other interested individuals with the components of diabetes care, general treatment goals, and tools to evaluate the quality of care. While individual preferences, comorbidities, and other patient factors may require modification of goals, targets that are desirable for most patients with diabetes are provided. These standards are not intended to preclude clinical judgment or more extensive evaluation and management of the patient by other specialists as needed. For more detailed information about management of diabetes, refer to references 1–3. The recommendations included are screening, diagnostic, and therapeutic actions that are known or believed to favorably affect health outcomes of patients with diabetes. A grading system (Table 1), developed by the American Diabetes Association (ADA) and modeled after existing methods, was used to clarify and codify the evidence that forms the basis for the recommendations. The level of evidence that supports each recommendation is listed after each recommendation using the letters A, B, C, or E. These standards of care are revised annually by the ADA multidisciplinary Professional Practice Committee, and new evidence is incorporated. Members of the Professional Practice Committee and their disclosed conflicts of interest are listed in the Introduction. Subsequently, as with all position statements, the standards of care are reviewed and approved by the Executive Committee of ADA’s Board of Directors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The finding for diabetes was also unchanged when a cutoff for glycated hemoglobin of 6.5% or more was used in local analysis, consistent with the 2010 ADA recommendation30 (hazard ratio, 0.49; 95% CI, 0.38 to 0.64).”
From Pioglitazone after Ischemic Stroke or Transient Ischemic Attack (2016) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Group based training for self-management strategies in people with type 2 diabetes mellitus
Deakin, T. A., McShane, C. E., Cade, J. E., & Williams, R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003417.pub2 · Cited by 862
RetractedToprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Research works printed but not linked: 9
- American Diabetes Asociation Medical Management of Type 1 Diabetes. Alexandria, VA, American Diabetes Association, 2008
- Heisler M: Building Peer Support Programs to Manage Chronic Disease: Seven Models for Success. Oakland, CA, California Health Care Foundation, 2006
- Aiello LP Wong J Cavallerano J Bursell SE Aiello LM: Retinopathy. In Handbook of Exercise in Diabetes. 2nd ed. Ruderman N Devlin JT Kriska A: Eds. Alexandria, VA, American Diabetes Association, 2002, p. 401– 413
- Vinik A Erbas T: Neuropathy. In Handbook of Exercise in Diabetes. 2nd ed. Ruderman N Devlin JT Kriska A: Eds. Alexandria, VA, American Diabetes Association, 2002, p. 463– 496
- Mogensen CE: Nephropathy. In Handbook of Exercise in Diabetes. 2nd ed. Ruderman N Devlin JT Kriska A: Eds. Alexandria, VA, American Diabetes Association, 2002, p. 433– 449
- American Diabetes Association: Psychosocial factors affecting adherence, quality of life, and well-being: Helping Patients cope. In Medical Management of Type 1 Diabetes. 5 ed. Francine R Kaufman: Ed. Alexandria, VA, American Diabetes Association, 2008, p. 173– 193
- Baigent C Keech A Kearney PM Blackwell L Buck G Pollicino C Kirby A Sourjina T Peto R Collins R Simes R: Cholesterol Treatment Trialists' (CTT) Collaborators Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267– 1278 16214597 · DOI · Paper page
- Buse JB Ginsberg HN Bakris GL Clark NG Costa F Eckel R Fonseca V Gerstein HC Grundy S Nesto RW Pignone MP Plutzky J Porte D Redberg R Stitzel KF Stone NJ: American Heart Association, American Diabetes Association Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 2007; 30: 162– 172 17192355 · DOI · Paper page
- US Preventive Services Task Force Counseling to Prevent Tobacco Use and Tobacco-Related Diseases: Recommendation Statement. Rockville, MD, Agency for Healthcare Research and Quality, 2003
Cited by
Items 1,001–1,022 of 1,022
Benhamza, M., Dahlui, M., & Said, M. A. (2024) · BMC Ophthalmology · doi:10.1186/s12886-024-03665-6 · Cited by 32
“However, it can be prevented if appropriate management is introduced early, which could reduce the risk of vision loss by 60% [4].”
BackgroundMinder, A. E., Albrecht, D., Schäfer, J., & Zulewski, H. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.12.024 · Cited by 28
Liu, J., Ge, Y., Wu, S., Ma, D., Xu, W., Zhang, Y., & Yang, Y. (2019) · Aging · doi:10.18632/aging.101781 · Cited by 27
Hompesch, M., Muchmore, D. B., Morrow, L., Ludington, E., & Vaughn, D. E. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0117 · Cited by 25
A comparison among three maximal mathematical models of the glucose-insulin system
Pompa, M., Panunzi, S., Borri, A., & De Gaetano, A. (2021) · PLOS ONE · doi:10.1371/journal.pone.0257789 · Cited by 24
Bird, D., Oldenburg, B., Cassimatis, M., Russell, A., Ash, S., Courtney, M. D., Scuffham, P. A., Stewart, I., Wootton, R., & Friedman, R. H. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-599 · Cited by 24
“Self-management is an integral component of effective diabetes care [5].”
Sinclair, K. A., Zamora-Kapoor, A., Townsend-Ing, C., McElfish, P. A., & Kaholokula, J. K. (2020) · BMC Public Health · doi:10.1186/s12889-020-09690-6 · Cited by 23
Beyond A1C: exploring continuous glucose monitoring metrics in managing diabetes
Friedman, J. G., Coyne, K., Aleppo, G., & Szmuilowicz, E. D. (2023) · Endocrine Connections · doi:10.1530/ec-23-0085 · Cited by 22
Tosur, Z., Green, D., De Chavez, P. J., Knutson, K. L., Goldberger, J. J., Zee, P., Liu, K., Kim, K.-Y., & Carnethon, M. R. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.04.005 · Cited by 21
Warner, J. V., Wu, J. Y., Buckingham, N., McLeod, D. S. A., Mottram, B., & Carter, A. C. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0129 · Cited by 20
Modeling Glucagon Action in Patients With Type 1 Diabetes
Emami, A., Youssef, J. E., Rabasa-Lhoret, R., Pineau, J., Castle, J. R., & Haidar, A. (2017) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2016.2593630 · Cited by 20
“by repeated capillary glucose measurements [4].”
Frenken, M., Cho, E. Y., Karcz, W. K., Grueneberger, J., & Kuesters, S. (2011) · Journal of Obesity · doi:10.1155/2011/860169 · Cited by 17
Pramlintide: Clinical Strategies for Success
Alrefai, H. A., Latif, K. A., Hieronymus, L. B., Weakley, C. R., & Moss, R. J. (2010) · Diabetes Spectrum · doi:10.2337/diaspect.23.2.124 · Cited by 16
Laparoscopic adjustable gastric banding and progression from impaired fasting glucose to diabetes
Wentworth, J. M., Hensman, T., Playfair, J., Laurie, C., Ritchie, M. E., Brown, W. A., Skinner, S., Shaw, J. E., & O’Brien, P. E. (2014) · Diabetologia · doi:10.1007/s00125-013-3129-0 · Cited by 16
Reproducibility of a prediabetes classification in a contemporary population
Chadha, C., Pittas, A. G., Lary, C. W., Knowler, W. C., Chatterjee, R., Phillips, L. S., Aroda, V. R., Lewis, M. R., Pratley, R., Staten, M. A., et al. (2020) · Metabolism Open · doi:10.1016/j.metop.2020.100031 · Cited by 15
Cho, N. H., Ahn, C. H., Moon, J. H., Kwak, S. H., Choi, S. H., Lim, S., Park, K. S., Metzger, B. E., & Jang, H. C. (2016) · Medicine · doi:10.1097/md.0000000000004582 · Cited by 15
Review of studies on the effect of bile acid sequestrants in patients with type 2 diabetes mellitus
Levy, P. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0087 · Cited by 15
Operationalizing and examining family planning vigilance in adult women with type 1 diabetes
Sereika, S. M., Becker, D., Schmitt, P., Powell, A. B., Diaz, A. M., Fischl, A. F. R., Thurheimer-Cacciotti, J., Herman, W. H., & Charron-Prochownik, D. (2016) · Diabetes Care · doi:10.2337/dc16-1648 · Cited by 15
Sharp, L. K., Biggers, A., Perez, R., Henkins, J., Tilton, J., & Gerber, B. S. (2021) · JMIR Research Protocols · doi:10.2196/17170 · Cited by 11
Ali, M. K., Singh, K., Kondal, D., Devarajan, R., Patel, S. A., Menon, V. U., Varthakavi, P. K., Vishwanathan, V., Dharmalingam, M., Bantwal, G., et al. (2024) · PLOS Medicine · doi:10.1371/journal.pmed.1004335 · Cited by 10
Sacks, D. B. (2012) · Tietz Textbook of Clinical Chemistry and Molecular Diagnostics · doi:10.1016/b978-1-4160-6164-9.00046-9 · Cited by 7
Evaluation of Point of Care Analyzer for Hemoglobin A1c
Dupuy, A. M., Badiou, S., Bargnoux, A. S., Russello, J., & Cristol, J. P. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818814544 · Cited by 2
Metadata
- Authors
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-01-01
- Volume
- 33
- Issue
- Supplement_1
- Pages
- S11-S61
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2797382
- OpenAlex
- W2596624061
- Cited by
- 3,470
- References
- 434
- Citations by year
- 2026: 55 · 2025: 71 · 2024: 101 · 2023: 121 · 2022: 113 · 2021: 168 · 2020: 130 · 2019: 140 · 2018: 143 · 2017: 140 · 2016: 193 · 2015: 233 · 2014: 255 · 2013: 284 · 2012: 372
- FWCI
- 301.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- diabetes mellitus, diabetes management, glycemic control, diabetes complications
- MeSH terms
- Diabetes Mellitus, Humans, Physicians, Risk Factors, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.